logo

For the Inventor, By the Inventor

Exton, PA, United States of America

John Timothy Lonsdale

This inventor holds 13 USPTO granted patents. Top assignees: Smithkline Beecham Corporation, Affinium Pharmaceuticals, Inc.. Active years: 1998-2006.

IDiyas Innovation Intelligence. (2026). Inventor Profile: John Timothy Lonsdale. Retrieved from https://idiyas.com/inventor/john-timothy-lonsdale

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

USPTO Granted Patents = 13

% Patents Active = 92.3

Average Co-Inventor Count = 4.3

ph-index = 4

Forward Citations = 65(Granted Patents)


Company Filing History:

goldMedal10 out of 2,198 
 
Smithkline Beecham Corporation
 patents
silverMedal3 out of 33 
 
Affinium Pharmaceuticals, Inc.
 patents

Years Active: 1998-2006

Loading Chart...
13 patents (USPTO):Explore Patents
1. 6995254 - [object Object] (2006-02-07),
2. 6951729 - High throughput screening method for biological agents affecting fatty acid biosynthesis (2005-10-04),
3. 6753172 - FabI (2004-06-22),
4. 6489139 - FabZ from Staphylococcus aureus (2002-12-03),
5. 6432670 - Polynucleotides encoding staphylcoccal FAB I enoyl-ACP reductase (2002-08-13),
6. 6294364 - Human FAS (2001-09-25),
7. 6294357 - FabF from Staphylococcus aureus (2001-09-25),
8. 6258934 - FabD (2001-07-10),
9. 6168797 - FabF (2001-01-02),
10. 5885572 - FabH (1999-03-23),
11. 5827689 - FabD polynucleotides (1998-10-27),
12. 5783432 - FabH (1998-07-21),
13. 5759832 - FabH (1998-06-02),

Title: John Timothy Lonsdale: Innovator in Biotechnological Advancements

Introduction

John Timothy Lonsdale is a prominent inventor based in Exton, Pennsylvania, known for his significant contributions to biotechnology. With a total of 13 patents to his name, Lonsdale has made remarkable strides in the field of polypeptides and DNA encoding, particularly in relation to bacterial infections.

Latest Patents

Lonsdale's latest patents include groundbreaking work on prokaryotic FAB I polypeptides and the DNA (RNA) encoding such FAB I. His research discloses a procedure for producing these polypeptides through recombinant techniques. Additionally, he has developed methods for utilizing FAB I in the treatment of infections, including bacterial infections. His patents also cover antagonists against FAB I and their therapeutic applications for treating infections, such as staphylococcal infections. Furthermore, Lonsdale has created diagnostic assays for detecting diseases associated with the presence of FAB I nucleic acid sequences and polypeptides in hosts. Another notable patent involves a high-throughput screening method for biological agents that affect fatty acid biosynthesis, which includes a detailed process for measuring the activity of enzymatic pathways.

Career Highlights

Throughout his career, Lonsdale has worked with notable companies such as SmithKline Beecham Corporation and Affinium Pharmaceuticals, Inc. His work has significantly impacted the biotechnology sector, particularly in the development of therapeutic and diagnostic solutions.

Collaborations

Lonsdale has collaborated with esteemed colleagues, including David John Payne and Stewart Campbell Pearson, contributing to various innovative projects in the field.

Conclusion

John Timothy Lonsdale's contributions to biotechnology through his patents and collaborations highlight his role as a key innovator in the industry. His work continues to influence the development of treatments and diagnostics for bacterial infections.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…